carmustine has been researched along with Infection, Postoperative Wound in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaichana, KL | 1 |
| Kone, L | 1 |
| Bettegowda, C | 1 |
| Weingart, JD | 1 |
| Olivi, A | 1 |
| Lim, M | 1 |
| Quinones-Hinojosa, A | 1 |
| Gallia, GL | 1 |
| Brem, H | 1 |
| Muntasser, H | 1 |
| Liaquat, I | 1 |
| Barlow, A | 1 |
| Whittle, I | 1 |
2 other studies available for carmustine and Infection, Postoperative Wound
| Article | Year |
|---|---|
Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation.
Topics: Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Carmustine; Combined Modality Therapy; Co | 2015 |
Gliadel wafers acting as a lattice for bacterial growth: a case illustration.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Brain Neoplasms; Carmustine; Central Nervous System | 2011 |